MELISANA PHARMA
Philippe BRET is an accomplished sales director and consultant with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Directeur ventes nationales at MELISANA PHARMA since September 2022, Philippe previously held significant roles, including Développement Commercial & Force de Vente at ITG Groupe, where responsibilities involved operational consulting, transition management, and training from November 2017 to October 2022. Philippe's background also includes leadership as Sales Director for Pfizer France, overseeing diverse product categories and managing a sales force from September 2008 to April 2016. Additional roles span regional management at Wyeth Médication familiale and Whitehall Pharmaceutical, initiating digital transformation and enhancing business models across various markets. Philippe holds certifications in Quality of Life at Work and has a robust educational foundation, including studies in Pharmacy and Transactional Analysis.
This person is not in the org chart
This person is not in any teams
MELISANA PHARMA
Melisana Pharma est née de la fusion de plusieurs laboratoires pharmaceutiques avec des marques emblématiques comme Dermophil, Hepatoum ou Fuca.